Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 784 across all filing types
Latest filing 2022-05-05 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 April 2022
Regulatory Filings Classification · 95% confidence The document is a detailed monthly report on movements in securities, specifically focusing on authorized and issued share capital, share options, repurchases, and confirmations related to securities issued by PW Medtech Group Limited. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The content is regulatory in nature, reporting share capital changes and confirmations but does not contain financial statements, earnings data, or management discussion. It is not an annual or interim report, nor an earnings release or investor presentation. It is a regulatory filing reporting share capital movements and confirmations as required by the stock exchange rules. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (8789 characters) and detailed content support this classification with high confidence.
2022-05-05 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for PW Medtech Group Limited, a listed issuer on the Stock Exchange of Hong Kong. It details repurchase of shares, including dates, number of shares, prices, and confirmations of compliance with listing rules. The content focuses on share repurchase activity and capital changes rather than financial results, management commentary, or regulatory certifications. The document is about a transaction in the company's own shares (share buybacks). Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail confirm it is not a brief announcement or a certification but a substantive disclosure of share repurchase activity.
2022-04-25 English
NOTICE OF THE 2022 ANNUAL GENERAL MEETING
AGM Information Classification · 95% confidence The document is titled 'NOTICE OF THE 2022 ANNUAL GENERAL MEETING' and contains detailed information about the agenda items for the upcoming AGM, including resolutions to be passed, re-election of directors, authorization of share repurchase and allotment mandates, and procedural notes for shareholders. It does not contain the actual financial statements or reports but is a formal notice announcing the meeting and its agenda. The document length is about 9,986 characters, which is consistent with a detailed notice but not a full annual report or financial statement. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting, including notices of the meeting.
2022-04-21 English
Form of Proxy for use at the Annual General Meeting to be held on Wednesday, June 8, 2022
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Form of Proxy for use at the Annual General Meeting (AGM) of PW Medtech Group Limited. It includes instructions for shareholders to appoint proxies to vote on resolutions at the AGM, including adoption of audited financial statements, re-election of directors, appointment of auditors, and share repurchase and issuance mandates. The content is typical of proxy materials distributed to shareholders prior to an AGM to facilitate voting. It is not the AGM presentation itself, nor the actual Annual Report or financial statements, but a proxy solicitation document related to the AGM. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI). The document length (7105 characters) and content confirm it is a proxy form, not a report publication announcement or regulatory filing.
2022-04-21 English
PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES OF THE COMPANY AND PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS OF THE COMPANY AND NOTICE OF THE 2022 ANNUAL GENERA
AGM Information Classification · 95% confidence The document is a circular from PW Medtech Group Limited related to the 2022 Annual General Meeting (AGM). It includes information about the proposed granting of general mandates to repurchase shares and to issue new shares, the proposed re-election of retiring directors, and the notice of the 2022 AGM. It contains detailed explanations, proxy arrangements, and appendices with explanatory statements and director details. The document is not a report of voting results, nor is it a brief announcement or a proxy solicitation alone. It is a comprehensive circular providing information to shareholders ahead of the AGM, which is typical of AGM Information filings. The presence of the notice of the AGM and detailed information about the meeting and resolutions confirms this classification. The document length (15,000 characters) and content confirm it is not a short announcement or a report publication announcement. Therefore, the document fits the category of AGM Information (AGM-R).
2022-04-21 English
ANNUAL REPORT 2021
Annual Report Classification · 100% confidence The document is titled 'ANNUAL REPORT 2021' and contains detailed sections typical of a full annual report, including corporate profile, definitions, corporate information, milestones, key financials, financial summary, chairman's statement, profile of directors and senior management, management discussion and analysis, financial review, corporate governance report, environmental, social and governance report, directors' report, independent auditor's report, and financial statements with notes. The content includes comprehensive financial data for the year ended December 31, 2021, and detailed narrative on business operations and outlook. The document length is substantial (15,000 characters), indicating it is the full report rather than an announcement or summary. Therefore, this document fits the definition of an Annual Report (10-K). FY 2021
2022-04-21 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.